Beryl Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

0.87

1.01

0.98

-0.95

0.35

Net cashflow-operating activity

2.64

0.82

2.48

-0.29

0.38

Net cash used in investing activity

-0.40

-1.08

-1.30

0.54

0.26

Netcash used in fin. activity

-1.55

0.10

-1.17

-0.43

-0.58

Net inc/dec in cash and equivlnt

0.69

-0.16

0.01

-0.18

0.06

Cash and equivalnt begin of year

0.12

0.28

0.27

0.45

0.40

Cash and equivalnt end of year

0.81

0.12

0.28

0.27

0.45